Fundraising Fox

Theranica Bio-Electronics

Founded 2016 · 4 known investors

theranica.com ↗

Theranica develops prescription digital therapeutics for pain management, including Nerivio, a wearable device that uses remote electrical neuromodulation of upper arm nerves to trigger the body's Conditioned Pain Modulation mechanism. Its products target neurological pain conditions such as migraine and offer a drug-free alternative for patients.

Digital HealthHealthtechMedical Devices

Investors · 4

LionBirdTel Aviv · $200K – $500K
Vivo CapitalPalo Alto · $10M – $50M
aMoonreportedRa'anana
Lightspeed Venture PartnersreportedMenlo Park · $1.7M – $87M

In the news

Theranica raises $35m Series B for neuromod migraine patch - MassDevicemassdevice.com · Mar 2019Theranica Raises $6M to Combat Migraineprnewswire.com · Jul 2017Theranica Bio-Electronics announces closing of its round A of financing | Reutersreuters.com · Jul 2017Theranica Raises $6M in Series A Funding - FinSMEsfinsmes.com · Jul 2017Theranica Bio-Electronics Closes Seed Financing Round - FinSMEsfinsmes.com · Sep 2016Theranica Announces the Closing of Seed Funding Round and Reports Promising Clinical Results in Acute Migraine Study Using its Proprietary Wearable Technologyprnewswire.com · Sep 2016

Frequently asked questions

What does Theranica Bio-Electronics do?
Theranica develops prescription digital therapeutics for pain management, including Nerivio, a wearable device that uses remote electrical neuromodulation of upper arm nerves to trigger the body's Conditioned Pain Modulation mechanism. Its products target neurological pain conditions such as migraine and offer a drug-free alternative for patients.
Who are Theranica Bio-Electronics's investors?
Theranica Bio-Electronics's investors include LionBird, Vivo Capital, aMoon, Lightspeed Venture Partners.